Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma

Oncology

Volumn 62, Issue 3, 2002, Pages 228-233

  Okusaka, Takuji ^a   Okada, Shuichi ^a   Ueno, Hideki ^a   Ikeda, Masafumi ^a   Iwata, Ryoko ^a   Furukawa, Hiroyoshi ^a   Takayasu, Kenichi ^a   Moriyama, Noriyuki ^a   Sato, Tosiya ^b   Sato, Keiko ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b KYOTO UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Japan)

Author keywords

Hepatocellular carcinoma; Lipiodol accumulation; Transcatheter arterial embolization; Zinostatin stimalamer

Indexed keywords

IODINATED POPPYSEED OIL; ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BIOACCUMULATION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CATHETER; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG ACCUMULATION; EVALUATION; FEMALE; HEPATIC ARTERY; HUMAN; LIPOPHILICITY; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RESPONSE TIME; SURVIVAL RATE; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MALEIC ANHYDRIDES; MIDDLE AGED; POLYSTYRENES; SURVIVAL RATE; TREATMENT OUTCOME; ZINOSTATIN;

EID: 18444381151     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000059570     Document Type: Article

References (21)

1. Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma
2. A lipophilic derivative of neocarcinostatin. A polymer conjugation of an antitumor protein antibiotic
3. Conjugation of poly(styrene-co-maleic-acid) derivatives to the antitumor protein neocarzinostatin: Pronounced improvements in pharmacological properties
4. Use of oily contrast medium for selective drug targeting to tumor: Enhanced therapeutic effect and X-ray image
5. Hepatocellular carcinoma: Treatment with intraarterial iodized oil with and without chemotherapeutic agents
6. Unresectable hepatocellular carcinoma: Analysis of prognostic factors in transcatheter management
7. Toxicity and response criteria of the Eastern Cooperative Oncology Group
8. Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma
9. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma
10. Nonparametric estimation from incomplete observations
11. Conjugates of anticancer agents and polymers. Advantages of macromolecular therapeutics in vivo
12. Tumoritropic and lymphotropic principles of macromolecular drugs
13. Augmentation of tumor delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure
14. Effect of arterial administration of high-molecular weight anti-cancer agent, SMANCS, with lipid lymphographic agent on hepatoma: A preliminary report
15. Tailor making of protein drugs by polymer conjugation for tumor targeting: A brief review on SMANCS
16. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
17. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
18. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution
19. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial
20. Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma